Related Experiment Video
Updated: May 20, 2026

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Development of 'DFG-out' inhibitors of gatekeeper mutant kinases
Hwan Geun Choi1, Jianming Zhang, Ellen Weisberg
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Abstract:
HG-7-85-01(22) and HG-7-86-01(26) are thiazolo[5,4-b]pyridine containing type II tyrosine kinase inhibitors with potent cellular activity against both wild-type and 'gatekeeper' mutant T315I- Bcr-Abl. Here we report on the 'hybrid design' concept and subsequent structure activity guided optimization efforts that resulted in the development of these inhibitors.
Related Concept Videos
Inhibition of Cdk Activity
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway

